Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WMBF News,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
News Channel 6,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WRCB- TV,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
KTRE,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
NewsWest9,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
South Carolina News Now,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
KLTV,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WTOC,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WDAM - TV,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WFMJ,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
Mississippi News Now ,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WTOL,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
News 9,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
2 News,
Information contained on this page is provided by an independent third-party content provider.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
Kuam,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
KTEN,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
KSLA News 12,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
ABC 7 News KSWO,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WTVM,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
KUSI News,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
NewsOn6,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
KAIT-TV,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
KHQ,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
14 News,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
Cleveland 19,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WMC Action News 5,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
NBC12,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WBOC 16,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
CBS8,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WDRB,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
azfamily.com,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WAND 17,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
Fox 14 News,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
Erie News Now,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
NBC Right Now KNDU 25,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
Hawaii News Now,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WLOX,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
News Channel,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WISTV,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
KPLC 7 News,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
48 WAFF,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WSFA ,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
KFVE The Home Team,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
Wave 3 News,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WFLX Fox 29,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
WALB,
SOURCE The Emmes Corporation Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md.
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
Ticker Tech,
/PRNewswire-USNewswire/ -- The Emmes Corporation today announced that Dr. Paul VanVeldhuisen, chief operating officer and…
Emmes Recognized in Eye Disease Research Published by the Journal of the American Medical Association
PR Newswire,
Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators News provided by 08:30 ET Share this article ROCKVILLE, Md.
Emmes Group Recognized In Eye Disease Research Published By The Journal Of The American Medical Association
Biospace,
Dr. Paul VanVeldhuisen was One of the Authors and Study Investigators ROCKVILLE, Md., May 17, 2017 /PRNewswire-USNewswire/ -…
Bevacizumab Effective for Macular Edema Due to Central Retinal Vein Occlusion
Medscape,
NEW YORK (Reuters Health) - Bevacizumab is as effective as aflibercept for improving visual acuity in patients with macular…
Avastin as effective as Eylea for treating central retinal vein occlusion
Medical News Today,
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the…
Avastin non-inferior to Eylea in Phase III CRVO trial
BioCentury,
NIH’s National Eye Institute (NEI) reported that intravitreal Avastin bevacizumab was non-inferior to Eylea aflibercept on the…
Avastin non-inferior to Eylea in Phase III CRVO trial
BioCentury,
NIH’s National Eye Institute (NEI) reported that intravitreal Avastin bevacizumab was non-inferior to Eylea aflibercept on the…
Avastin as Effective as Eylea for Treating Central Retinal Vein Occlusion
Drug Discovery and Development ,
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the…
Low Cost Bevacizumab as Effective as Aflibercept Drug for Central Retinal Vein Occlusion
Medindia,
Highlights Central retinal vein occlusion (CRVO) occurs when the vein carrying the blood flow to the retina is blocked.
Avastin as effective as Eylea for treating central retinal vein occlusion
Technology.org,
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the…
Two widely used drugs show effectiveness in treating patients with CRVO-associated macular edema
Health Medicinet,
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the…
Avastin as Effective as Eylea for Treating Central Retinal Vein Occlusion
Science Newsline,
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the…
Two widely used drugs show effectiveness in treating patients with CRVO-associated macular edema
The Medical News,
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the…
NIH-Funded Clinical Trial Shows Avastin Is as Effective as Eylea for Treatment of Central Retinal Vein Occlusion
Newswise,
Return to Article List Use of either drug improved vision and had few side effects Article ID: 674326 Released: 8-May-2017 11:15…
Avastin as effective as Eylea for treating central retinal vein occlusion
MedicalXpress,
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the…
Avastin as effective as Eylea for treating central retinal vein occlusion
Foreign Affairs New Zealand,
NIH-funded clinical trial shows use of either drug improved vision and had few side effects.
Avastin as effective as Eylea for treating central retinal vein occlusion
EurekAlert!,
Monthly eye injections of Avastin (bevacizumab) are as effective as the more expensive drug Eylea (aflibercept) for the…